A Patient Perspective on the recent #KDOQI Commentary:
Guidance on Care for Autosomal Dominant Polycystic Kidney Disease
bit.ly/4bIyDEt (FREE)
#ADPKD @nkf-professionals.bsky.social
Check out the most popular articles from the January-December 2025 issues of AJKD:
bit.ly/AJKDPopularC... (FREE)
#KDOQI US Commentary on the @kdigo.org 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of #ADPKD
bit.ly/KDOQIADPKD26 (FREE)
Complement Inhibition in Immunoglobulin A Nephropathy: A Mini-Review
bit.ly/49n58Xx (FREE)
AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing.
Apply by April 30. Details: bit.ly/3Z64pFG
Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study
bit.ly/3MLdj8z
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY
bit.ly/3WA9uoy (OPEN ACCESS)
IN A FEW WORDS essay by Jonathan S. Pollack: The Roller Coaster Ride of IgA Nephropathy
bit.ly/4vFDAas (FREE)
EDITORIAL: Post-Transplant Bone Loss: How Muscles, Parathormone, and Steroids Come Into Play
bit.ly/4siYSs2 (FREE)
Proposed mechanism of action for remote ischemic preconditioning. Multiple mechanisms for remote ischemic preconditioning have been suggested. A novel mechanism of action shown here involves high-mobility group Box-1 (HMGB-1) and possibly other molecules, released from muscle in response to transient ischemia. Transcriptomic imprinting of renal tubular epithelial cells occurs following signal transduction from engagement of HMGB-1 with Toll-like receptor 4 (TLR-4) on proximal tubular epithelial cells.
Remote Ischemic Preconditioning: Is This Star Still Rising?
bit.ly/4crPbAV (FREE)
On the #AJKDBlog:
Timothy Yau sat down with Sixto Giusti to discuss Kidney Transplant Outcomes Among Hispanic Recipients:
bit.ly/4gyksUC
New from #NephFaculty Dr Strasma and colleagues in AJKD
Environmental Threats to Kidney Health: A Clinician's Guide to Modern Exposures
https://pubmed.ncbi.nlm.nih.gov/41921740/
In A Few Words essay by Robert Sanchez, MPS:
Why This Research Matters
bit.ly/49zsxGw
Radiology imaging of pediatric ADPKD-IFT140 cases. (A, B) Case IFT1-IV-2: MRI at 17 years of age showing 12 cysts on the right kidney and 16 on the left. The largest measures 26 mm on the lower pole of the right and 4 cm on the upper pole of the left. The majority are <5 mm in length. A: Coronal T2 image (MRI) with the arrow pointing to the 4 cm cyst with internal septation located at the upper pole of the left kidney. B: Coronal T2 MRI with the arrow pointing at the 26 mm simple cyst on the lower pole of the right kidney. (C, D) Case IFT1-IV-4: Ultrasound imaging at 4 years of age showing 3 cysts on the right kidney and none on the left. All cysts measured 2-5 mm. Longitudinal ultrasound pictures of the right kidney with the arrow pointing at the cysts. (E, F) Case IFT2-III-5: Ultrasound imaging at 9 months old showing multiple cysts on the right kidney with a 3 cm cyst on the upper pole and a 0.7 cm cyst on the left kidney.
Monoallelic IFT140 Variants Causing Childhood-Onset Autosomal Dominant Polycystic Kidney Disease
bit.ly/3J9ZIWT
Fellowship training confidence by clinical exposure. Proportion of fellows rating themselves as “well-trained”. Abbreviations: PD, peritoneal dialysis; HHD, home hemodialysis.
A Survey of Home Dialysis Competency, Exposure & Barriers Among Nephrology Fellows in the United States
bit.ly/4tlky7B (OPEN ACCESS)
Dialysis saves lives but may also impact brain health.
What do changes in cerebral blood flow and oxygenation mean for patients?
Listen to the discussion in this Kidney Commute: Pit Stop episode.
bit.ly/3DamjQ9 (Episode 052)
#ESKD #Dialysis #Nephrology
In the Literature by Michelle M. Estrella:
Sex Hormones and Effects on Kidney Health: Piecing Together the Science
bit.ly/4mt126B
Check out the most popular articles from the January-December 2025 issues of AJKD:
bit.ly/AJKDPopularC... (FREE)
AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing.
Apply by April 30. Details: bit.ly/3Z64pFG
What is Medicare Advantage and Why is it the Most Important Contemporary Policy Affecting Kidney Disease?
bit.ly/4o1O2Ed
Dilution Modes in Hemodiafiltration. Released under a CC BY 3.0 license from Imamovic et al
Hemodiafiltration: A Mini Review
bit.ly/4awrvuf
Commentary by Api Chewcharat on the #AJKDBlog:
Stiff Arteries, Fragile Kidneys: The Link to Chronic Kidney Disease
bit.ly/4nq3GJl
Article by Zhiqi Yao et al: bit.ly/Yao25OI #OpenAccess
Acute Kidney Injury in a Patient With Metastatic Leiomyosarcoma: A Quiz
bit.ly/3Oip73k (FREE)
• What is the differential diagnosis for the acute kidney injury in this patient?
• What is the cause of rhabdomyolysis in this patient?
Representation of Adults with CKD in Major Endovascular Stroke Trials
bit.ly/4vsVnBF (FREE)
📢FRIENDLY REMINDER:
US-based physicians have until June 1, 2026 to claim CME for #NephMadness: bit.ly/NM26CME
Don't procrastinate!
@nkf-professionals.bsky.social
If you submitted a #NephMadness bracket, check your score here: bit.ly/2GZNoEl
Congrats to Santimoreno457 with a perfect bracket!
Stay tuned for the winners announcement next week...
Catch up on the champion team from #NephMadness IgA Nephropathy Region
Expert: Laura Mariani
Writer: Alessandra Tomasi
Execs: @nephrosparks.bsky.social & Dia Waguespack
bit.ly/NM26IgAN
Here is the final 2026 bracket with B-cell Modulators crowned as champion!
To Commiserate or Celebrate: #NephMadness
bit.ly/NM26Champ
How did the #NephMadness crowd vote?
37% for 🏆Team B-cell Modulators🏆 followed by 11% for Team Natural Language Processing
bit.ly/NM26Champ
🏆Team B-cell Modulators🏆 wins 7-2 against C3G Treatment
#NephMadness BRP:
“Worthy final round. 2025-26 will forever be known as the year IgA nephropathy became cool again. A year ago people had never heard of APRIL and now it’s the hottest topic. B-cell therapies for the win!”
bit.ly/NM26Bcell